![]() ![]() 2 Guidelines for secondary prevention of ischemic stroke recommend a variety of antiplatelet medications. 1 Antiplatelet therapy reduces the risk of recurrent ischemic stroke, particularly those that are of noncardioembolic origin, and is the treatment of choice. 1 Each year, more than 795,000 people in the United States experience a stroke, 87% of which are ischemic. Stroke is a leading cause of death and disability. Although single antiplatelet therapy is the standard for stroke prevention, some data suggest that short courses of dual antiplatelet therapy in selected patients may provide additional protection against recurrent stroke. Aspirin, clopidogrel, and aspirin/extended-release dipyridamole are the most commonly used agents. The American Heart Association/American Stroke Association and the American College of Chest Physicians have published guidelines that provide recommendations on antiplatelet therapy for secondary prevention of ischemic stroke. ABSTRACT: Antiplatelet therapy has been shown to reduce the risk of recurrent stroke in patients who have already experienced a noncardioembolic ischemic stroke or transient ischemic attack.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |